Archive for the ‘Gene Therapy Research’ Category

Vlad #39;s Grow Titan Genetics: Dawg #39;s Breath Ep. 1
Test grow for Titan Genetics: (Stardawg x Alien Kush f2) X Tennesee Hawg #39;s Breath For more information visit: http://www.nwgt.org

By: Vladamyr

Read more here:
Vlad's Grow Titan Genetics: Dawg's Breath Ep. 1 - Video

Virology Lecture 2013 #3 - Genomes and genetics
A discussion of the seven different types of viral genome, and the pathway to mRNA, followed by an overview of modern viral genetic analysis.

By: Vincent Racaniello

See original here:
Virology Lecture 2013 #3 - Genomes and genetics - Video

TGA Dairy Queen Apollo 13 BX OG Kush Chem Dawg -TLO Style
TGA Dairy Queen Apollo 13 BX OG Kush Chem Dawg Giving a long needed update on the Garden. Finally have some real genetics in which are OG Kush, TGA Genetics Dairy Queen, TGA Genetics Apollo 13 BX Chem Dawg... Using the TLO Style of Growing or True Living Organics Style of Growing developed by The Rev of Skunk Magazine. You can use the link below to Purchase his book if you haven #39;t gotten it already. http://www.amazon.com

By: HowtoGrowCannabis

Read the original post:
TGA Dairy Queen Apollo 13 BX OG Kush

Trophy Key Deer Buck
This is a Trophy Buck down on Big Pine Key. Key deer are small, on a Island, with limited food supply, God #39;s Genetics limit physical size. No doubt, if a Key Deer population moved back to the mainland, (because genetically they #39;re identical to regular White tail Deer) in a few generations they #39;d return to regular white tail size. Compared to midwest cornfed deer, Key deer are dwarfs. Foolishly, Darwin credits "Evolution" for this characteristic, but actually, the fact that Genetics adapts within a range, is much GREATER proof God designed the system, not less. Satan #39;s confused adaptation or micro evolution with macro evolution, which violates the laws of probability and is physiologically impossible.

By: John Johnson

Read the original:
Trophy Key Deer Buck - Video

Fitness Advice, Workout Videos, Motivation, Health Fitness - Tell It Like It Is #44
Nav-Vii shows you his exact workout routines, shares his best workouts and diet plans that he does to construct a super fit body on his popular blog http://www.bodynv.tv In this video, Nav-Vii goes on a rant about how much genetics or cheating play in achieving goals. He explains that although he has been blessed with good genetics, the main reason he has been able to achieve his fitness goals is through consistent hard work. Nav-Vii does not believe in excuses or copouts about why you can #39;t achieve your fitness goals. He then mentions recent athletes who have been caught cheating and explains; with or without cheating, those athletes would still be great at their sport. In the Tell It Like It Is series, Nav-Vii goes on a rant about various interesting topics. This is a very entertaining segment that he does for his Bodynv.tv followers (NV Nation). Nav-Vii never fails to entertain and provides insight on topics ranging from obesity, motivational quotes, mindset of champions, diet tips and many other topics of discussion. Nav-Vii is an advocate for not resting between exercises and has a strict rule to complete each workout in less than 25 minutes. This time challenge is what makes it much more difficult than traditional workouts. The high intensity aspects of Nav-Vii #39;s workouts rival the most intense interval training you will ever do! The style of Nav-Vii #39;s workout program is sure to challenge even the most dedicated. In addition to proven workout tips, Nav-Vii guides his NV ...

By: Bodynvtv

Read more:
Fitness Advice, Workout Videos, Motivation, Health

Deocding Perubian Burial Stones and Linking Renniassance Art To Them By Gerone Wright
Attached in this video are my ongoing discoveries in which links our genetic ancestory to tht of the genetics of the dinosaur. The discovery of the perubian burial stones and thier encsriptions are being misconstrued. It would never be proved that mankind coexisted with dinosuars and even if it could science would reject the ideal. However, it can be proved that mankind has genectically evolved through the genetics of dinosuars. There are many ancient records that show us who we truly are, however, mainstream science has distorted our ancient genetic evolution to the point of us looking past the factual records that were left behind for us realize our genetic becoming what we are today. My videos are revealing a true look into the reality. For those of you that have an open mind you cane experience all the reality in what stating and and now experience the true lite. For those of you that have close mind you will remain in dark and remain being faslely lead in understanding to your demise. Gerone Wright

By: Geroneification

The rest is here:
Deocding Perubian Burial Stones and Linking Renniassance Art To Them By Gerone Wright - Video

Evolution #39;s Failed Predictions
What do mice and fruit flies have in common? On the surface, you #39;d not think much, but geneticists have discovered that some of their genes are practically identical. Discoveries like this are often touted as proof of evolution because the similar genes supposedly show that mice and fruit flies are related. But evolutionary scientists did not predict this. Genetics professor Sean Caroll confessed, "No biologist had even the foggiest notion that such similarities could exist between genes of such different animals." According to evolutionists, mice and fruit flies last shared a common ancestor over six hundred million years ago, therefore any common genes they possessed should have been scrambled beyond recognition by almost countless generations of mutations. Different animals share similar genes, not because they are related, but because they had a common designer who used a similar blueprint to build the animal kingdom and that was not very long ago either. Related Articles: Common Design points to common ancestry argument (creation.com Homologous Structures (creation.com Saddle up the horse off to the batcave (creation.com Related Products: Creation Answers Book (creation.com If animals could talk (creation.com What about arguments for Evolution Tract (creation.com

By: CMIcreationstation

Visit link:
Evolution's Failed Predictions - Video

Newswise AUSTIN, Texas For centuries, the fate of the original Otom inhabitants of Xaltocan, the capital of a pre-Aztec Mexican city-state, has remained unknown. Researchers have long wondered whether they assimilated with the Aztecs or abandoned the town altogether.

According to new anthropological research from The University of Texas at Austin, Wichita State University and Washington State University, the answers may lie in DNA. Following this line of evidence, the researchers theorize that some original Otomies, possibly elite rulers, may have fled the town. Their exodus may have led to the reorganization of the original residents within Xaltocan, or to the influx of new residents, who may have intermarried with the Otom population.

Using ancient DNA (aDNA) sampling, Jaime Mata-Mguez, an anthropology graduate student and lead author of the study, tracked the biological comings and goings of the Otom people following the incorporation of Xaltocan into the Aztec empire. The study, published in American Journal of Physical Anthropology, is the first to provide genetic evidence for the anthropological cold case.

Learning more about changes in the size, composition, and structure of past populations helps anthropologists understand the impact of historical events, including imperial conquest, colonization, and migration, Mata-Mguez says. The case of Xaltocan is extremely valuable because it provides insight into the effects of Aztec imperialism on Mesoamerican populations.

Historical documents suggest that residents fled Xaltocan in 1395 AD, and that the Aztec ruler sent taxpayers to resettle the site in 1435 AD. Yet archaeological evidence indicates some degree of population stability across the imperial transition, deepening the mystery. Recently unearthed human remains from before and after the Aztec conquest at Xaltocan provide the rare opportunity to examine this genetic transition.

As part of the study, Mata-Mguez and his colleagues sampled mitochondrial aDNA from 25 bodies recovered from patios outside excavated houses in Xaltocan. They found that the pre-conquest maternal aDNA did not match those of the post-conquest era. These results are consistent with the idea that the Aztec conquest of Xaltocan had a significant genetic impact on the town.

Mata-Mguez suggests that long-distance trade, population movement and the reorganization of many conquered populations caused by Aztec imperialism could have caused similar genetic shifts in other regions of Mexico as well.

In focusing on mitochondrial DNA, this study only traced the history of maternal genetic lines at Xaltocan. Future aDNA analyses will be needed to clarify the extent and underlying causes of the genetic shift, but this study suggests that Aztec imperialism may have significantly altered at least some Xaltocan households.

See the original post here:
Aztec Conquest Altered Genetics among Early Mexico Inhabitants, New DNA Study Shows

Published: Jan. 31, 2013 at 11:17 AM

ST. LOUIS, Jan. 31 (UPI) -- Doctors may one day treat some forms of blindness by altering the genetic program of the light-sensing cells of the eye, U.S. researchers say.

Senior author Dr. Joseph Corbo, an assistant professor of pathology and immunology at Washington University School of Medicine in St. Louis, said working with mice with retinitis pigmentosa -- a disease that causes gradual blindness -- the researchers reprogrammed the cells in the eye that enable night vision.

The change made the cells more similar to other cells that provide sight during daylight hours and prevented degeneration of the retina, the light-sensing structure in the back of the eye, Corbo said.

The scientists said they were conducting additional tests to confirm that the mice could still see.

"We think it may be significantly easier to preserve vision by modifying existing cells in the eye than it would be to introduce new stem cells," Corbo said in a statement. "A diseased retina is not a hospitable environment for transplanting stem cells."

The study was published in the early online edition of Proceedings of the National Academy of Sciences.

More:
Gene therapy developed to treat blindness

By JENNIFER NOBLIT

ThisWeek Community News Wednesday January 30, 2013 3:54 PM

Dublin students next year will get a chance to investigate gene therapy, cellular biology and other biomedical subjects through a new academy.

Dublin City Schools' Biomedical Research Academy will kick off next fall, offering credits in Advanced Placement Biology, body systems, medical interventions, introduction to biomedical research, 3D art and technical writing.

"There's been a big movement in science education to incorporate more (science, technology, engineering and math)-based learning. So Dublin, as usual, is trying to stay on the cutting edge of these kinds of programs," said Roger Rabold, who will teach the year-long academy.

The district asked Rabold to design the academy that is open to all Dublin high school students and will be taught at Scioto High School for three periods in the afternoon.

The academy is one of four available to students next fall and is funded by a STEM grant from Race to the Top, said Eydie Schilling executive director of learning and teaching.

"We're doing a lot of planning to get the academies ready," Schilling said.

"The STEM grant will support the Biomedical Research Academy, the Environmental Academy, Engineering Academy and Business Academy."

Rabold won't be the only one to educate the new academy, though.

View post:
Dublin's Biomedical Research Academy begins in fall

Washington, January 30 (ANI): According to a study, women with harmful mutations in the BRCA gene, which put them at higher risk of developing breast and ovarian cancer, tend to undergo menopause significantly sooner than other women, allowing them an even briefer reproductive window and possibly a higher risk of infertility.

Moreover, the study led by researchers at UC San Francisco showed that carriers of the mutation who are heavy smokers enter menopause at an even earlier age than non-smoking women with the mutation.

While the authors note that further research is needed, given the size and demographics of the study, women with the abnormal gene mutation should consider earlier childbearing, and their doctors should encourage them to initiate fertility counseling along with other medical treatments, the scientists said.

This is the first controlled study to explore the association between BRCA1 and BRCA 2 and the age at onset of menopause, the researchers said.

"Our findings show that mutation of these genes has been linked to early menopause, which may lead to a higher incidence of infertility,'' said senior author Mitchell Rosen, MD, director of the UCSF Fertility Preservation Center and associate professor in the UCSF Department of Obstetrics, Gynecology and Reproductive Sciences.

"This can add to the significant psychological implications of being a BRCA1/2 carrier, and will likely have an impact on reproductive decision-making,'' Rosen said.

The researchers looked at nearly 400 female carriers of mutations in the BRCA gene in northern California and compared their onset of menopause to that of 765 women in the same geographic area without the mutation. Most of the women in the study were white because almost all of the BRCA1/2 carriers within the UCSF cancer risk registry are white.

The scientists found that women with the harmful mutation experienced menopause at a significantly younger age - 50 years-compared to age 53 for the other midlife women.

Heavy smokers (more than 20 cigarettes a day) with the abnormal gene had an even earlier onset of menopause -- 46 years.

The authors point out that while their study shows a possible increased risk of infertility for the mutation carriers, further study is needed.

See more here:
Abnormal gene mutation causes early menopause in women

TORONTO - Canadian researchers have used the power of genomics to identify the cause of a rare Parkinson's-like disease in children of one extended family and come up with a treatment to help reverse its effects.

It's believed to be the first time a new disease has been discovered, its cause figured out and a treatment successfully determined in such a short time, in this case about two years.

The eight children five boys and three girls born to four sets of parents in a large Saudi Arabian family were born with symptoms similar to those experienced by adults with Parkinson's disease, said principal researcher Dr. Berge Minassian, a neurologist at Toronto's Hospital for Sick Children.

"They're very interesting, they're like little babies with Parkinson's disease," said Minassian, explaining that the children exhibited typical symptoms of the neurological disorder, including tremors, problems executing movements, and the flat facial expression known as a "masked face."

"Those kids are like that. They cry, but you don't see them cry," he said.

Dr. Reem Alkhater, a pediatric neurology resident at the hospital, has been travelling back and forth between Toronto and Saudi Arabia as part of the research team's investigations into the familial disorder.

The children are part of an unidentified family of Bedouin ancestry living in a western Saudi city whose members had intermarried through several generations. Known as consanguineous marriages, the offspring of such unions have a one in four chance of inheriting mutated genes if they are carried by both parents.

"When you have consanguinity, then you end up with problems where you get the bad copy from each side because the two sides are related," said Minassian. "In this case, consanguinity played a role in these children being sick and having this autosomal recessive disease."

Using genomic sequencing, the Toronto scientists pinpointed a common mutated gene among the children, known as SLC18A2. (The genome is all the genetic material in a person or any other organism.)

The gene, which is involved in the production of the brain chemicals dopamine and serotonin, had a single genetic-letter misprint, which dramatically reduced its function and produced the Parkinson's-like disorder, he said.

Here is the original post:
Researchers pinpoint gene behind rare disorder in kids, treat successfully

Published: Jan. 30, 2013 at 5:49 PM

SAN FRANCISCO, Jan. 30 (UPI) -- Women with mutations in the BRCA gene, which put them at higher risk of breast and ovarian cancer, tend to undergo menopause sooner, U.S. researchers say.

Senior author Dr. Mitchell Rosen of the University of California, San Francisco, showed carriers of the mutation who are heavy smokers enter menopause at an even earlier age than non-smoking women with the mutation.

"Our findings show that mutation of these genes has been linked to early menopause, which may lead to a higher incidence of infertility,'' Rosen said in a statement. "This can add to the significant psychological implications of being a BRCA1/2 carrier, and will likely have an impact on reproductive decision-making."

Rosen said further research is needed, given the size and demographics of the study, women with the abnormal gene mutation should consider earlier childbearing, and their doctors should encourage them to initiate fertility counseling along with other medical treatments.

The researchers looked at nearly 400 female carriers of mutations in the BRCA gene in northern California and compared their onset of menopause to that of 765 women in the same geographic area without the mutation.

The scientists found that women with the harmful mutation experienced menopause at age 50 compared to age 53 for the women without the gene.

However, heavy smokers -- more than 20 cigarettes a day -- with the BRCA gene had an even earlier onset of menopause -- age 46. By comparison, only 7 percent of white women in northern California had undergone menopause by that age, the study said.

The study was published online in Cancer.

Read the original here:
Menopause sooner if women have cancer gene

Genetic Engineering and Selective Breeding
This video will go over two types of genetic engineering; recombinant DNA and gene transfer. It will also discusse how selective breeding works.

By: mrfox218

Read more:
Genetic Engineering and Selective Breeding - Video

Food / Industrial Enzymes from Reade
A new era of advances in enzyme technology now exists. Genetic engineering is being applied, not only to source valued enzymes in easier-to-grow microorganisms but also to modify and tailor enzyme protein properties to customer requirements. Companies are exploring extreme environments in search of enzymes having properties more in tune with industrial needs. Researchers are applying molecular evolution to stretch and alter enzyme specificities. Enzymes are being harnessed to work in partially organic solvents so they can have new applications.

By: ReadeInternational

See original here:
Food / Industrial Enzymes from Reade - Video

Oncolytic viruses kill cancer cells: oncolytic virus research. Future health care, chemo, oncology
More: http://www.virttu.com. How oncolytic viruses work to kill cancer cells. Replication of oncolytic viruses inside tumours. Pre-clinical trials. Phase I, Phase II and Phase III clinical trials on oncolytics. Use of oncolytic viruses to treat advanced malignant melanoma and mestatases -- Amgen research using an oncolytic virus developed from HSV (Herpes Simplex Virus). Oncolytic virus conference 2013. Problems with traditional chemotherapy -- side effects. Why Amgen bought an oncolytic viruse for $500m in cash and $500m to be paid if oncolytic trials are fully successful. Investor interest in oncolytic viruses. Oncolytic virus fund. Lessons from the history of research and development in monoclonal antibodies in cancer treatment. Why targeted cancer therapy -- a so-called "magic bullet" is so needed. How oncolytic viruses have been modified so that they cannot replicate in normal cells, but are still able to divide in a wide variety of human cancer cells. History of oncolytic viruses. Arming oncolytic viruses. Using viruses like Seprehvir (HSV-1716), adapted to carry an additional payload extra genes which teach infected cancer cells to take up a compound containing radioactive iodine from the blood, delivering a micro-dose of radiation inside individual cancer calls. Or adding a gene which teaches cancer cells how to split a harmless pro-drug into two, inside the cell, releasing a very effective chemotherapy (alkylating agent). Targetting oncolytic viruses -- by adapting the ...

By: pjvdixon

Read the rest here:
Oncolytic viruses kill cancer cells: oncolytic virus research. Future health care, chemo, oncology - Video

Dr. Matthew Porteus on genetically editing T-cell DNA to fight HIV/AIDS
Dr. Matthew Porteus, associate professor of pediatrics at Stanford Medical School and a pediatric hematologist/oncologist at Lucile Packard Children #39;s Hospital, talks with Etopia News host Marc Strassman about using genetic engineering techniques to modify T-cells so that they will be immune to infection by HIV, recorded from Stanford, California, on January 30, 2013.

By: etopianews

Read more from the original source:
Dr. Matthew Porteus on genetically editing T-cell DNA to fight HIV/AIDS - Video

Public release date: 30-Jan-2013 [ | E-mail | Share ]

Contact: Vicki Cohn vcohn@liebertpub.com 914-740-2100 Mary Ann Liebert, Inc./Genetic Engineering News

New Rochelle, NY, January 30, 2013Metabolic syndrome is more likely to affect children who are obese than overweight or non-overweight and who have other characteristics associated with the disorder, such as high blood pressure or insulin resistance. A new comprehensive and systematic review of the medical literature on metabolic syndrome in children that probed deeper to evaluate the risk associated with gender, ethnicity, and geography was published in Metabolic Syndrome and Related Disorders, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers. The article is available on the Metabolic Syndrome and Related Disorders website at http://www.liebertpub.com/met.

Amanda Friend, MBChB, Leone Craig, PhD, and Steve Turner, MD, University of Aberdeen, Scotland, assessed data from 85 studies and reported their findings in the article "The Prevalence of Metabolic Syndrome in Children: A Systematic Review of the Literature." Overall, the prevalence of metabolic syndrome increased substantially when comparing groups of overweight or obese children to whole populations of youths.

The authors found significant differences in metabolic syndrome prevalence for boys versus girls and for older compared to younger children. Some evidence suggested that there may also be an association between ethnicity and region of the world where a child lives and the prevalence of metabolic syndromea possible link that warrants further study.

"The authors should be lauded for their comprehensive and careful review of a group that has been largely ignored, which is children," says Ishwarlal (Kenny) Jialal, MD, PhD, Editor-in-Chief of the Journal and Director of the Laboratory for Atherosclerosis and Metabolic Research and Professor of Internal Medicine at the University of California, Davis Medical Center (Sacramento). "They clearly show that increasing age, male sex, and adiposity are risk factors for metabolic syndrome in children. They also emphasize the need for future studies to confirm the reported increased prevalence in certain ethnic groups."

###

About the Journal

Metabolic Syndrome and Related Disorders is the only peer-reviewed journal focusing exclusively on the pathophysiology, recognition, and treatment of metabolic syndrome. The Journal covers a range of topics including insulin resistance, central obesity, glucose intolerance, dyslipidemia with elevated triglycerides, predominance of small dense LDL-cholesterol particles, hypertension, endothelial dysfunction, and oxidative stress and inflammation. Complete tables of content and a sample issues may be viewed on the Metabolic Syndrome and Related Disorders website at http://www.liebertpub.com/met.

About the Publisher

Originally posted here:
Are gender and ethnicity risk factors for metabolic syndrome in children?

TORONTO, Jan. 30, 2013 /CNW/ - For the first time in Canada, patients attending a family practice clinic will be offered genetic testing to see whether or how they will respond to psychiatric medication treatment, in partnership with the Centre for Addiction and Mental Health (CAMH).

Thornhill Medical Centre, a clinic of family physicians, is making the promise of personalized medicine a reality.

"These pharmacogenetic tests will enable physicians to use a patient's genetic makeup to help predict which medications are safe to prescribe, and which ones may be ineffective or cause side effects," said Dr. James Kennedy, head of CAMH's Neuroscience Research Department.

The tests, which will prevent trial-and-error prescribing and reduce associated health-care costs, will be analyzed in the Tanenbaum Centre for Pharmacogenetics at CAMH's Campbell Family Mental Health Research Institute.

"My patients were ready for these tests yesterday - they may have tried three or four different antidepressants that didn't work or had side effects, before finding something that helped them," Dr. Nick Voudouris, a family physician with the Thornhill Medical Centre. "The ability to be able to know which medications patients will respond to, based on their genetic predisposition, is invaluable."

Using a saliva sample, variations on five genes are analyzed to predict a patient's response to 19 common antidepressant and antipsychotic medications. Medications that will work get a green light to prescribe as directed. A yellow light signals caution. For each medication in this category, the tests will show whether dosing levels need to be lowered or increased, or that the drug's effects may not be optimal for this patient. Medications in the red light category should be used with caution and more frequent monitoring, due to side effects or lack of response.

This initiative is part of the larger IMPACT study (Individualized Medicine: Pharmacogenetic Assessment & Clinical Treatment). Funded in part by the Ontario Ministry of Economic Development and Innovation, IMPACT researchers aim to look at the impact of genetic testing over seven years in 20,000 patients. They are also seeking to identify new genetic markers.

"We expect these tests to improve patient satisfaction and safety, and have a substantial impact on reducing health-care costs, which we will be examining over the course of the IMPACT study," said Dr. Kennedy. "With the genetic information doctors will be better equipped to prevent complications from medications before they occur."

Thornhill Medical Centre was chosen because its team includes seven general practitioners and numerous registered nurses caring for a diverse array of patients who can be monitored on a fully implemented electronic medical record. This system helps track important research information as well. All clinic physicians agree that genetic information is important to study in terms of medication response and side effects, and has a great benefit for patient care, Dr. Voudouris noted.

The Centre for Addiction and Mental Health (CAMH) is Canada's largest mental health and addiction teaching hospital, as well as one of the world's leading research centres in its field.

See the article here:
In a Canadian first, family practice offers genetic testing with CAMH to predict which psychiatric meds work best

Seoul (The Korea Herald/ANN) - Yuhan Corporation, a Seoul-based pharmaceutical company, said Tuesday that it had launched a genetic information analysis service that tracks down personal genetic risks for certain diseases and disorders.

In a joint venture with Theragen Etex, a local biotech firm specializing in genetic code analysis, Yuhan introduced "Hello Gene" that tests personal genetic information with just a few drops of blood, the company said. The service interprets ones genetic information within a week or two and predicts what kind of diseases or disorders the person is vulnerable to. It will also design a new lifestyle tailored to the individuals genetic and phenotypic information, the company added.

"We are experiencing a paradigm shift to (new) medical technology and service that offers ways to prevent diseases, long before they start treating them," a Yuhan official told reporters in Seoul.

The genetic information technology will open the data-driven medicine of tomorrow that improves treatment effectiveness and minimizes the side effects of drugs, he added.

The Korean drug maker plans to expand R&D investment on developing personalized medicine such as new drugs tailored to ones genetic information and technological devices that would offer more accurate diagnosis to patients.

Yuhan pinned higher hopes on the genetic information analysis market in the near future as the government rolled out plans to develop the countrys competitiveness in genomics last year.

In November, the Korean government said it would invest 579 billion won in genomics research over the next eight years to create and support related industries in the field.

Korea has been lagging behind other advanced economies in the study of genomics, a division of genetics research, officials said, adding that the technological gap between Korea and the U.S., the worlds biggest biotech country, is widening.

Follow this link:
Korean pharmaceutical firm launches genetic analysis service

Public release date: 30-Jan-2013 [ | E-mail | Share ]

Contact: Michael Torres media@camh.ca 416-595-6015 Centre for Addiction and Mental Health

For the first time in Canada, patients attending a family practice clinic will be offered genetic testing to see whether or how they will respond to psychiatric medication treatment, in partnership with the Centre for Addiction and Mental Health (CAMH).

Thornhill Medical Centre, a clinic of family physicians, is making the promise of personalized medicine a reality.

"These pharmacogenetic tests will enable physicians to use a patient's genetic makeup to help predict which medications are safe to prescribe, and which ones may be ineffective or cause side effects," said Dr. James Kennedy, head of CAMH's Neuroscience Research Department.

The tests, which will prevent trial-and-error prescribing and reduce associated health-care costs, will be analyzed in the Tanenbaum Centre for Pharmacogenetics at CAMH's Campbell Family Mental Health Research Institute.

"My patients were ready for these tests yesterday they may have tried three or four different antidepressants that didn't work or had side effects, before finding something that helped them," Dr. Nick Voudouris, a family physician with the Thornhill Medical Centre. "The ability to be able to know which medications patients will respond to, based on their genetic predisposition, is invaluable."

Using a saliva sample, variations on five genes are analyzed to predict a patient's response to 19 common antidepressant and antipsychotic medications. Medications that will work get a green light to prescribe as directed. A yellow light signals caution. For each medication in this category, the tests will show whether dosing levels need to be lowered or increased, or that the drug's effects may not be optimal for this patient. Medications in the red light category should be used with caution and more frequent monitoring, due to side effects or lack of response.

This initiative is part of the larger IMPACT study (Individualized Medicine: Pharmacogenetic Assessment & Clinical Treatment). Funded in part by the Ontario Ministry of Economic Development and Innovation, IMPACT researchers aim to look at the impact of genetic testing over seven years in 20,000 patients. They are also seeking to identify new genetic markers.

"We expect these tests to improve patient satisfaction and safety, and have a substantial impact on reducing health-care costs, which we will be examining over the course of the IMPACT study," said Dr. Kennedy. "With the genetic information doctors will be better equipped to prevent complications from medications before they occur."

Read the original here:
Family practice offers genetic tests to predict effective psychiatric meds, a CAMH study

Marketing beef globally and locally
Blairs.Ag, a seedstock operation based in Saskatchewan, Canada, markets Angus, Red Angus and Hereford genetics to producers in Canada and around the world. At the National Western Stock Show in Denver, Chad Haaland describes how the operation also has begun marketing beef directly to local consumers.

By: CattleNetwork

Read this article:
Marketing beef globally and locally - Video

Miami Plastic Surgery - Facelift with Fat Grafting
As we get older, aging of the face is inevitable. Time, gravity, exposure to the sun and genetics all contribute to the signs of aging of the face and neck. Skin begins to sag, deep creases form, and fat and volume are lost. A facelift, or rhytidectomy, can be performed to reduce the visible signs of aging of the face and neck by tightening the skin and deeper tissues. However, simply tightening the facial skin and underlying structures will not replace the volume that is lost, and because of that, fat grafting can often be performed in conjunction with the facelift. Through fat grafting, fat cells can be transferred from unwanted areas to areas of the face that are deficient. For more information or to schedule a consultation with Dr. Michael Kelly, please contact Miami Plastic Surgery at (305) 595-2969 or visit our website at http://www.miamiplasticsurgery.com.

By: MiamiPlasticSurgery

Read the original post:
Miami Plastic Surgery - Facelift with Fat Grafting - Video

Science Project CJ
Genetics daw ?

By: Charisma Joy Vergara

The rest is here:
Science Project CJ - Video

Accelerated Genetics Cooperative Initiative Year in Review
2011-2012 was a big year for Accelerated Genetics and our cooperative. This video shares some of the highlights.

By: Accelerated Genetics

Excerpt from:
Accelerated Genetics Cooperative Initiative Year in Review - Video